, Tracking Stock Market Picks
Enter Symbol:
Genentech, Inc. (DNA) [hlAlert]

up 21.19 %

Genentech, Inc. (DNA) rated Buy with price target $91 by Caris & Company

Posted on: Monday,  Feb 25, 2008  9:25 AM ET by Caris & Company

Caris & Company rated Buy Genentech, Inc. (NYSE: DNA) on 02/25/2008, when the stock price was $78.36. Since
then, Genentech, Inc. has gained 21.20% as of 03/26/2009's recent price of $94.97.
If you would have followed this Caris & Company's recommendation on DNA, you would have gained 21.19% of your investment in 395 days.

Genetic Technologies was the first company in the world to recognize important new applications for `non-coding` DNA (DeoxyriboNucleic Acid). The Company has since been granted patents securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all multicellular species.

Caris & Company, an investment bank created by a diverse group of leading Wall Street professionals. We are founded on the basic principle that Wall Street requires a different type of organization: One that offers objective, conflict-free research, acute focus on customer service, broad institutional coverage, and an unwavering commitment to increasing the value of our clients' portfolios. Quite simply, our goal is to generate solid investment ideas for our clients. We offer a unique, differentiated, conflict-free research perspective on large, mid, and small capitalization companies in four growth oriented verticals: Health Care, Technology, Energy, and Consumer.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/25/2008 9:25 AM Buy
78.36 91.00
as of 12/24/2008
1 Week up  15.67 %
1 Month up  0.49 %
3 Months up  12.65 %
1 YTD up  19.79 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy